• How Oxidative Stress Activates ATM: Structural Insights

  2026-08-18

  Howes, Perisic, and Williams used cryo-EM and biochemical analysis to define how hydrogen peroxide activates the DNA damage kinase ATM. Their structure links a redox-sensitive disulfide bridge to dimer rotation, release of an autoinhibitory region, kinase-domain remodeling, and productive p53 substrate binding.

• TAI-1 Hec1 Inhibitor: Workflows & Applications

  2026-08-18

  TAI-1 gives cancer researchers a practical route to connect Hec1–Nek2 disruption with mitotic failure, proliferation loss, and apoptotic cell death induction. This guide combines dose-response, chromosome-imaging, combination-treatment, and replication-stress assays with troubleshooting strategies for triple negative breast cancer research and liver cancer research.

• Chenodeoxycholic Acid: From FXR Signal to Assay Design

  2026-08-17

  Chenodeoxycholic Acid (CDCA) is more than an FXR agonist: it can serve as a mechanistic probe linking bile acid metabolism to transcriptional and injury-response assays. This guide translates recent FXR–KLF11 findings into a rigorous framework for experimental design, controls, and interpretation.

• Central Control of Opioid Mechanical Hypersensitivity

  2026-08-17

  Yin et al. identify a brain-to-spinal opioid pathway linking MOR-expressing neurons in the lateral parabrachial nucleus, dynorphin neurons in the hypothalamus, and KOR-expressing GABAergic neurons in the spinal dorsal horn. Their findings distinguish central control of mechanical opioid-induced hypersensitivity and tolerance from better-established thermal mechanisms and provide a circuit framework for receptor- and pathway-level experiments.

• ETS1–SENP2 Axis in Bronchopulmonary Dysplasia

  2026-08-16

  A 2026 study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating SENP2-dependent deSUMOylation, HSPA8 binding, and FUNDC1 degradation. The findings connect mitochondrial quality control with alveolar injury and suggest that excessive mitophagy, rather than autophagy activation in general, may be a context-dependent therapeutic target.

• Plant Cell Lysis Buffer for WB and IP: MAPK10 Assays

  2026-08-15

  Build cleaner Western blotting, immunoprecipitation, and co-IP workflows from plant, animal, fungal, or bacterial samples with a non-denaturing extraction system. This guide translates MAPK10–KRT16 pathway findings into practical sample-preparation, assay-selection, and troubleshooting decisions.

• hCG, H3K27 Methylation, and CXCL10 in Decidua

  2026-08-14

  The reference study identifies a hormone–chromatin–chemokine pathway in which trophoblast-derived hCG increases EZH2-associated H3K27me3 at the CXCL10 promoter in human decidual stromal cells. This mechanism links placental signaling to reduced CD8 T-cell recruitment and provides a useful framework for studying epigenetic control of immune adaptation at the maternal–fetal interface.

• T7 RNA Polymerase for Precise In Vitro RNA Synthesis

  2026-08-14

  T7 RNA Polymerase is a recombinant enzyme expressed in E. coli that selectively transcribes DNA templates carrying a T7 promoter. Its defined promoter recognition supports in vitro RNA synthesis for research workflows, including RNA vaccine production, antisense RNA, and RNAi studies.

• Bestatin (Ubenimex): Mechanism & Research Guide

  2026-08-13

  Bestatin, also called Ubenimex, is a research aminopeptidase inhibitor with reported activity against cytosol aminopeptidase, aminopeptidase N, zinc aminopeptidase, and aminopeptidase B. Its effects are assay-dependent: a peer-reviewed fibrin-matrix model found enhanced endothelial tube formation, so Bestatin should not be labeled universally anti-angiogenic.

• Optimized GBA1 mRNA for Gaucher Disease Therapy

  2026-08-13

  The reference study develops a rationally optimized human GBA1 mRNA platform that improves glucocerebrosidase expression, durability, and lysosomal delivery. In cellular and mouse experiments, the mRNA–lipid nanoparticle system restored disease-relevant enzyme function, supporting further investigation of mRNA therapy as an alternative or complement to enzyme replacement and substrate reduction strategies.

• PNU 74654: Designing Better Wnt Assays

  2026-08-12

  PNU 74654 is a Wnt signaling pathway inhibitor for testing how β-catenin-dependent signals shape cell fate. This guide focuses on causal assay design, controls, and responsible interpretation across cancer research, stem cell research, and muscle biology.

• Praeruptorin A, DMT1, and Ferroptosis in DIC

  2026-08-12

  This study used a ferrous-ion probe to screen herbal small molecules and identified Praeruptorin A as an intervention candidate for doxorubicin-induced cardiomyopathy. The evidence connects Praeruptorin A with reduced DMT1 expression, lower cardiomyocyte Fe2+ overload, suppressed ferroptosis, improved cardiac function, and retained doxorubicin antitumor activity.

• ABT-263 (Navitoclax) Apoptosis Workflow

  2026-08-11

  Build more informative apoptosis assays with ABT-263 (Navitoclax), from dose-response screening to mitochondrial mechanism validation. This workflow also translates a senescence-selective study into practical controls without overstating what Navitoclax has demonstrated in non-cancer tissues.

• CD28–ARS2–PKM2 Axis in CD8+ T Cells

  2026-08-11

  Holling and colleagues identify a CD28–ARS2 signaling axis that reshapes alternative splicing of PKM in activated CD8+ T cells, favoring PKM2 over PKM1. The work connects costimulation, RNA processing, glucose-use flexibility, interferon-γ production, and antitumor effector activity through a mechanism that is distinct from canonical CD28–PI3K signaling.

• Cardiogreen: From Vascular Imaging to PDT

  2026-08-10

  Cardiogreen, also known as Indocyanine green, connects vascular diagnostics with near-infrared therapeutic research. This guide translates its optical properties into practical workflows for cardiac output measurement, liver blood flow assessment, ophthalmic angiography, and photothermal or photodynamic assays in cancer models.

8578 records 6/572 page Previous Next First page 上5页 678910 下5页 Last page